Holliston

Holliston’s Harvard Bioscience has returned on course in the second quarter after a rocky start to the year, where it had a $4.5-million loss in the first quarter, according to its earnings report from Wednesday.

Workers at the Mayflower Medicinals cannabis cultivation facility in Holliston voted to join the United Food & Commercial Workers Union on Wednesday, making them among the first cannabis workers to unionize in the state, according to a Wednesday press release.

Kevin Young, Web Industries vice president of the company's medical device manufacturing business, spoke with WBJ about what it's like to expand during a pandemic and why the company decided to beef up its Holliston operations. 

James McGorry resigned as CEO of Holliston biotechnology company Biostage, Inc., officially leaving his position on Feb. 7, according to a company quarterly earnings report released in May. 

Marlborough-based Web Industries Inc. announced Thursday it will hire 125 skilled equipment operators, engineering personnel, bio scientists, quality assurance, purchasing and inventory specialists over the next three months at its Holliston facility.

Holliston’s Harvard Bioscience announced it had a $3.3-million operating loss in the first quarter of the year and predicted year-over-year losses would continue into the second quarter of the year.

Three public companies in Central Massachusetts have disclosed they received a combined $8.4 million in federal loans for the program intended to bailout small businesses.

Holliston-based Harvard Bioscience announced Thursday that Susan Steele has been appointed to the company’s Board of Directors as a Class III director in a move to appease an activist investor company planning to nominate their own board member candidates.

Holliston biotechnology firm Harvard Bioscience, Inc. has developed a new technology to provide researchers with real-time access to aerosol amounts deposited inside subjects' lungs, the company said in a press release.

In its fourth-quarter earnings report released Wednesday, Holliston biotech Harvard Bioscience announced it has started a restructuring program expected to save about $4 million, including laying off workers and closing its facilities.